Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
RA Capital Healthcare Fund LP bought 45,768 Artiva Biotherapeutics, Inc. shares (Form 4)
Traded Jul 29 to Jul 31, 2026 · Filed Jul 31, 2026
From Jul 29 to Jul 31, 2026, RA Capital Healthcare Fund LP (Director, 10% owner) bought 45,768 Artiva Biotherapeutics, Inc. shares at an average US$9.96 for US$456K, leaving 17,329,570 shares. Filed Jul 31, 2026 (Form 4).
- Bought
- 45,768 shares
- Price
- US$9.96 average (US$9.93 to US$9.99)
- Value
- US$456K
- Holding after
- 17,329,570 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Common Stock | Buy | 20,824 | US$9.99 | 17,304,626 | Indirect |
| Jul 31, 2026 | Common Stock | Buy | 24,944 | US$9.93 | 17,329,570 | Indirect |
Source
Related
- Artiva Biotherapeutics, Inc.
- RA Capital Healthcare Fund LP
- Artiva Biotherapeutics, Inc. shareholders
- Form 4 · RA Capital Healthcare Fund LP · Jul 20, 2026
- Form 4 · Aslan Fred · Oct 7, 2026
- Form 4 · Aslan Fred · Oct 6, 2026
- Form 4 · Banerjee Subhashis · Oct 6, 2026
- Form 4 · Bush Jennifer · Oct 6, 2026
- Form 4 · Horan Christopher · Oct 6, 2026